GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianhai Health Holdings Ltd (HKSE:00911) » Definitions » Revenue

Qianhai Health Holdings (HKSE:00911) Revenue : HK$961.3 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Qianhai Health Holdings Revenue?

Qianhai Health Holdings's revenue for the six months ended in Dec. 2023 was HK$621.4 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$961.3 Mil. Qianhai Health Holdings's Revenue per Share for the six months ended in Dec. 2023 was HK$3.67. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$5.67.

Warning Sign:

Qianhai Health Holdings Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Qianhai Health Holdings was -51.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 8.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 54.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was -12.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 11 years, Qianhai Health Holdings's highest 3-Year average Revenue per Share Growth Rate was 57.10% per year. The lowest was -69.80% per year. And the median was 9.75% per year.


Qianhai Health Holdings Revenue Historical Data

The historical data trend for Qianhai Health Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianhai Health Holdings Revenue Chart

Qianhai Health Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 587.81 760.72 283.40 1,961.70 961.29

Qianhai Health Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.68 1,201.28 760.43 339.90 621.39

Competitive Comparison of Qianhai Health Holdings's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Qianhai Health Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianhai Health Holdings's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianhai Health Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Qianhai Health Holdings's Revenue falls into.



Qianhai Health Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$961.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qianhai Health Holdings  (HKSE:00911) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Qianhai Health Holdings Revenue Related Terms

Thank you for viewing the detailed overview of Qianhai Health Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianhai Health Holdings (HKSE:00911) Business Description

Traded in Other Exchanges
N/A
Address
177-183 Wing Lok Street, Room 301-3, 3rd Floor, Wing Tuck Commercial Centre, Sheung Wan, Hong Kong, HKG
Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products and the sale of information technology components products. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products includes sale of healthcare products including Chinese herbal medicines, skincare and other healthcare products. Electronic component products includes sale of information technology components products including central processing unit and semiconductors. The group's revenue is all derived from Hong Kong.
Executives
Huang Guanchao 2101 Beneficial owner
Shinewing Sas (nominee Services) No. 3 Limited 2501 Other
Hou Chung Man 2501 Other
Tang Chung Wah 2501 Other
Sparkling Rock Limited 2201 Interest of corporation controlled by you
Chong Siew Hoong 2202 Interest of your spouse
Lim Tzea 2101 Beneficial owner
Explorer Rosy Limited
Great Prosperous Limited
Noble Stand Global Limited
Thousands Beauties Limited
Yunnan Energy Investment (h K) Co. Limited 2106 Person having a security interest in shares
Yunnan International Holding Group Limited 2106 Person having a security interest in shares
Yunnan International Supply Chain Limited 2106 Person having a security interest in shares
Yunnan Provincial Energy Investment Group Co., Ltd 2106 Person having a security interest in shares

Qianhai Health Holdings (HKSE:00911) Headlines

No Headlines